Clinical Trials Logo

Hospitalized Patients clinical trials

View clinical trials related to Hospitalized Patients.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04520880 Not yet recruiting - Clinical trials for Hospitalized Patients

Antibodies Responses to COVID-19 Infection in Hospitalized Patients

No-SARS
Start date: August 2020
Phase:
Study type: Observational

1.5. Why this clinical study? The prevalence of seropositivity following SARS-CoV 2 infection might have its own potential benefits in terms of predicting the end of pandemic and the validity of herd immunity. It is not clear if SARS-CoV 2 infection would have a long-lasting antibody-mediated immunity, and if the antibodies' persistence is dependent on disease severity.depends on the severity of illness. If evidence is provided about the persistence of antibodies that is reflective of the protective immune response, serodiagnosis will be an important tool to identify individuals with various risk for infection, and those who are in need of receiving the forthcoming vaccines. The here proposed prospective clinical study will test the prevalence of seropositivity following SARS-CoV 2 infection in critically ill patients compared to those who do not require intensive care unit (ICU) admission or invasive ventilation with respect to the IgM and IgG levels.